Professor | Wanjun Ding | Asia Growth Partners

Upload Avatar (500 x 500)

Name

Wanjun Ding

Contact Information

dingwanjun66@126.com

Language ability

English, Chinese

Province

Hubei

University/Lab Affiliation and Title	Wuhan University
Faculty	Medical School
Academic Background & Achievements	1998.09-2003.06 Bachelor's Degree: Tongji Medical College, Huazhong University of Science and Technology 2005.09-2011.06 Master's and PhD in Surgery: Wuhan University First Clinical College 2019.01-2020.01 Visiting Scholar: Johns Hopkins University School of Medicine, Cancer Research Center
Work Experience	2011.07-2014.11 Attending Physician, Oncology Center, Renmin Hospital, Wuhan University 2018.12-2022.11 Associate Chief Physician, Oncology Center, Renmin Hospital, Wuhan University 2022.12-present Chief Physician, Oncology Center, Renmin Hospital, Wuhan University
Awards	2014: Third Prize, Hubei Province Science and Technology Progress Award

University/Lab Affiliation and Title

Wuhan University

Faculty

Medical School

Academic Background & Achievements

1998.09-2003.06 Bachelor's Degree: Tongji Medical College, Huazhong University of Science and Technology
2005.09-2011.06 Master's and PhD in Surgery: Wuhan University First Clinical College
2019.01-2020.01 Visiting Scholar: Johns Hopkins University School of Medicine, Cancer Research Center

Work Experience

2011.07-2014.11 Attending Physician, Oncology Center, Renmin Hospital, Wuhan University
2018.12-2022.11 Associate Chief Physician, Oncology Center, Renmin Hospital, Wuhan University
2022.12-present Chief Physician, Oncology Center, Renmin Hospital, Wuhan University

Awards

Areas of Focus	Early non-invasive molecular diagnosis of malignant tumors Basic and clinical research on breast cancer and lymphoma
Publications	Selective ERK inhibitor ulixertinib inhibits proliferation and induces apoptosis in lymphoma cell lines, Wan-Jun Ding, Wei-Ping Tao, Tao Zeng, et al., 2016 Genes with mutation significance were highly associated with the clinical pattern of patients with breast cancer, Wan-Jun Ding, Tao Zeng, Li-Jun Wang, et al., 2017 Effect of lenalidomide on the human gastric cancer cell line SGC7901/vincristine Notch Signaling, Wanjun Ding, Tao Zeng, Weiping Tao, et al., 2018 Methylated markers accurately distinguish primary central nervous system lymphomas(PCNSL) from other CNS tumors, Bradley M. Downs, Wanjun Ding, et al., 2021 Intraductal administration of transferrin receptor-targeted immunotoxin clears ductal carcinoma in situ in mouse models of breast cancer—a preclinical study, Guannan Wang, Alok Kumar, Wanjun Ding, et al., 2022

Areas of Focus

Early non-invasive molecular diagnosis of malignant tumors
Basic and clinical research on breast cancer and lymphoma

Publications

Selective ERK inhibitor ulixertinib inhibits proliferation and induces apoptosis in lymphoma cell lines, Wan-Jun Ding, Wei-Ping Tao, Tao Zeng, et al., 2016
Genes with mutation significance were highly associated with the clinical pattern of patients with breast cancer, Wan-Jun Ding, Tao Zeng, Li-Jun Wang, et al., 2017
Effect of lenalidomide on the human gastric cancer cell line SGC7901/vincristine Notch Signaling, Wanjun Ding, Tao Zeng, Weiping Tao, et al., 2018
Methylated markers accurately distinguish primary central nervous system lymphomas(PCNSL) from other CNS tumors, Bradley M. Downs, Wanjun Ding, et al., 2021
Intraductal administration of transferrin receptor-targeted immunotoxin clears ductal carcinoma in situ in mouse models of breast cancer—a preclinical study, Guannan Wang, Alok Kumar, Wanjun Ding, et al., 2022

Molecular Diagnosis Non-Invasive Malignant Tumors Early Detection Breast Cancer Lymphoma Clinical Research Basic Research Oncology Tumor Markers

Yongchang Wei - Wuhan University

Xianlong Zhou - Wuhan University

Jing Chen - Wuhan University

View All

Personal Information